Our results demonstrate that Lkb1 is a critical regulator of BAT growth and function, and suggest that Lkb1 signalling may be therapeutically targeted to counteract obesity, diabetes and other metabolic diseases. The gene discussed is STK11; the disease is obesity disorder.